AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.

Add Yahoo as a preferred source to see more of our stories on Google. Dr Sue Pavord:’It was scary. I was a mother of three kids in their 20s, and these were the people we were seeing dying’ - ...

AstraZeneca is Britain's largest pharmaceutical company and is often cited as the biggest company of any sort in the UK, valued at more than £210bn. Its global headquarters are in Cambridge - the ...

Deutsche Bank has kept its sell rating and 11,500p price target on AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 ...

AstraZeneca CEO Pascal Soriot joins 'Mad Money' host Jim Cramer to talk quarterly results, drug development, AI integration, ...

President Donald Trump has not shied away from making demands of private industry, and he formalized one of them last week. On Thursday, he sent letters to 17 pharmaceutical companies, demanding that ...

Patients have been left frustrated and scared after learning that a life-saving breast cancer and endometriosis drug is to be ...

With a recent FDA nod for Baxfendy under its belt, AstraZeneca is looking to grow its prowess in cardio disease, weight ...

This drug is used to treat endometriosis and some breast cancers, but will soon be stripped from Australian shelves.